$HOMB

Allison John W II sold $53K of HOMB

Allison John W II sold 2,000 shares of HOME BANCSHARES INC (HOMB) at $26.38 on 2026-06-01.

Original reporting
SEC EDGAR · Allison John W II
Published Jun 2, 2026, 7:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 2, 2026, 7:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HOMB
Neutral
medium confidence
Mentioned
$HOMB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HOMBNeutralLow
01

Why it matters

The only new datapoint is the reported sale size, price, and that it was not under a pre-arranged 10b5-1 plan.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a major repricing.

03

What to watch

Consider whether there are multiple recent insider sales by the same director or other insiders; a single small sale often has low predictive value.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-02; sale executed 2026-06-01

Background

The article is an SEC Form 4 disclosure of an insider (director) open-market sale of HOME BANCSHARES shares; it does not include any earnings, guidance, or deal information.

Company-level read

Ticker impact

$HOMBNeutralMedium confidence
Context

Director Allison John W II sold 2,000 shares of HOME BANCSHARES on 2026-06-01 at $26.3750 via an open-market sale, disclosed on Form 4.

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a routine Form 4 insider transaction with no 10b5-1 plan and no accompanying company-specific operational or financial news.

Market effects

Minimal; this is company-specific insider activity with no stated sector-wide development.

Limited to the issuer; no broader regional banking catalyst mentioned.

None indicated.

Counterpoint

Without a 10b5-1 plan, the sale could be for liquidity/tax reasons rather than a bearish view on fundamentals.

Key entities

  • HOME BANCSHARES INC

    Subject of the Form 4 insider transaction disclosure.

  • Allison John W II

    Director who sold 2,000 shares on 2026-06-01.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HOMBMed

Home BancShares (HOMB) Q3 2026 Earnings Call Transcript

Home BancShares (HOMB) reported Q3 2026 earnings, highlighting a 9.5% dividend increase to $0.23/share, $39.3M in share buybacks (0.69% yield), and strong profitability. The company emphasized its disciplined balance sheet strategy, avoiding long-duration securities, and managing AOCI impact. Key metrics include a 4.53% net interest margin, 2.11% ROA, and 16.54% return on tangible common equity. Management expects recoveries on a large nonperforming loan and plans continued stock repurchases.

$HOMBMed

Piper Sandler lowers Home Bancshares price target to $34 on growth

Piper Sandler cut its price target on Home Bancshares (HOMB) to $34 from $36, citing Q3 2026 results that beat EPS estimates but showed loan and deposit declines. The firm adjusted EPS estimates for 2026-2028, highlighting improved net interest margin and share repurchases. HOMB reported record Q3 earnings of $129.1M ($0.65 EPS), beating estimates, but revenue missed expectations. Analysts focus on strong profitability and capital levels.

$HOMBMed

Home BancShares (HOMB) Q3 Results Meet Record Profit While Credit Risk Builds

Home BancShares (HOMB) reported Q3 results meeting record profits, with $850M in loan production and a 4.53% margin. Management is cautiously optimistic about Q4 growth but acknowledges volatility in loan demand and deposit competition. Concerns include unpredictable loan payoffs and reliance on acquisitions for growth. The company's stock is discussed in the context of potential mispricing.

$HOMBMed

Home BancShares Q3 Earnings Call Highlights

Home BancShares (HOMB) reported Q3 earnings, including a 9.5% dividend increase to $0.23 per share and $39.3M in share repurchases. The company expects to complete Mountain Commerce integration by Q4, with $5M in annualized cost savings. Loan production was $850M, with loan growth expected to improve. Legacy deposits declined by $358M. Management anticipates resolving a large Texas C&I nonaccrual credit, potentially recovering $10M.